Zoledronate after denosumab discontinuation: Is repeated administrations more effective than single infusion?

Published in: The Journal of clinical endocrinology and metabolism (2024)

In patients with uncontrolled CTX levels after Dmab withdrawal, two ZOL infusions at 6 months apart do not prevent BMD loss and FX.

Keyphrases